DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 2Dr. Reddy's Laboratories
02 1NanoAlvand
03 1Ever Pharma
04 1medac
05 1Advanz Pharma
06 1Baxter Healthcare Corporation
07 1Bayer AG
08 1Chia Tai Tianqing Pharmaceutical Group
09 5Eisai
10 5Eisai Inc
11 1Eisai Pharmaceuticals Africa (Pty) Ltd
12 1GLAND PHARMA LIMITED
13 1GSK
14 1JIANGXI KVVIT PHARM
15 1Long Grove Pharmaceuticals
16 1Natco Pharma (Canada) Inc
17 2STADA Arzneimittel
18 1Sandoz B2B
19 1Xiling Lab
20 1Yes Pharmaceutical Development Services Gmbh
21 1Zentiva
Reset all filters
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 1INJ
03 11Injectable Solution
04 1Injection
05 1Injection fluid, resolution
06 2SOLUTION
07 9SOLUTION;INTRAVENOUS
08 1Solution for Injection
09 4Blank
Reset all filters
01 1Allowed
02 10Approved
03 1Lead Market Dossiers- Filed
04 1Originator
05 9RX
06 9Blank
Reset all filters
01 8ERIBULIN MESYLATE
02 1Eribulin Advanz Pharma
03 1Eribulin Baxter
04 1Eribulin Ever Pharma
05 1Eribulin Glenmark
06 1Eribulin Medac
07 1Eribulin Stada
08 1Eribulin Stada Arzneimittel Ag
09 1Eribulin Zentiva
10 2HALAVEN
11 1Halave
12 8Halaven
13 1Mevlyq
14 1NAT-ERIBULIN
15 1Nibulin®
16 1Blank
Reset all filters
01 4Australia
02 2Canada
03 1India
04 1Iran
05 1Italy
06 1Norway
07 1South Africa
08 10Sweden
09 1Switzerland
10 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 217473
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Nibulin®
Dosage Form : Solution for Injection
Dosage Strength : 1MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 07/06/2024
Application Number : 2.02212E+13
Regulatory Info : Approved
Registration Country : Sweden
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Medac
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 2.02209E+13
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-10-01
Application Number : 217250
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-03-04
Application Number : 218743
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : RX
Registration Country : USA
Brand Name : HALAVEN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2010-11-15
Application Number : 201532
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Halaven
Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Halaven
Dosage Form : Injection fluid, resolution
Dosage Strength : 0.44 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Canada
Brand Name : HALAVEN
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging : 2ML
Approval Date :
Application Number : 2377438
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-04-05
Application Number : 218047
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-07-18
Application Number : 214850
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Brand Name : NAT-ERIBULIN
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number : 2539136
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-06-09
Application Number : 214310
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-08-05
Application Number : 218142
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-06-28
Application Number : 218281
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF